Position in GOSS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,650
-$3,402 QoQ
Shares Held
10,000
-34.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#149
of 168 holders
Holding Since
Mar 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ground Swell Capital, LLC holds $1,388,097 across 11 Biotechnology names. GOSS ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
4,320 | $411,134 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,475 | $361,035 | |
| 3 | CGON |
CG Oncology, Inc.
|
4,765 | $338,553 | |
| 4 | LNAI |
Lunai Bioworks Inc.
|
53,211 | $173,999 | |
| 5 | IVA |
Inventiva S.A.
|
12,803 | $48,395 | |
| 6 | GNTA |
Genenta Science S.p.A.
|
14,374 | $26,448 | |
| 7 | COCP |
Cocrystal Pharma, Inc.
|
10,752 | $11,289 | |
| 8 | TOVX |
Theriva Biologics, Inc.
|
35,292 | $8,823 |
All Filings in GOSS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,650 | 10,000 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,052 | 15,356 | Shares | Sole | 2026-04-21 | |
| 2023-03-31 | $16,930 | 13,437 | Shares | Sole | 2023-05-08 | |
| No filing history on record for this holder in this stock. | ||||||